New Age Alpha Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Sell
8,487
-265
-3% -$87.1K 0.12% 258
2025
Q4
$3.07M Buy
8,752
+590
+7% +$199K 0.13% 231
2025
Q3
$2.64M Sell
8,162
-106
-1% -$33K 0.11% 251
2025
Q2
$3.22M Sell
8,268
-2,179
-21% -$876K 0.14% 213
2025
Q1
$4.54M Buy
10,447
+109
+1% +$43.8K 0.2% 142
2024
Q4
$3.81M Buy
10,338
+10,309
+35,548% +$4.31M 0.15% 189
2024
Q3
$15.1K Buy
+29
New +$15.5K 0.01% 154

Other funds holding ELV

New Age Alpha Advisors's ELV Position: Q1 2026 in Review

New Age Alpha Advisors reduced its Elevance Health (ELV) stake by 3% in Q1 2026, selling an estimated $87.1K and leaving 8,487 shares worth $2.48M. The position accounts for 0.12% of the portfolio, ranked #258.

New Age Alpha Advisors first reported a position in ELV in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.54M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • New Age Alpha Advisors held 8,487 shares of Elevance Health worth $2.48M as of Q1 2026.
  • New Age Alpha Advisors sold 265 Elevance Health shares in Q1 2026, an estimated $87.1K.
  • Elevance Health made up 0.12% of New Age Alpha Advisors's portfolio in Q1 2026, its #258 holding.
  • New Age Alpha Advisors first reported a position in Elevance Health in Q3 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Elevance Health position peaked at $4.54M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.